Foundayo (orforglipron, approved April 1, 2026) is a small-molecule non-peptide compound, chemically different from semaglutide, and can be taken any time of day with no food or water restrictions
It reduces RBC mass and partially ameliorates the signs and symptoms of CMS
Ignoring Expiration: Even when stored perfectly, peptides don't last forever
Additionally, the downstream metabolism of fructose contributes to ROS generation through its consumption of ATP for its conversion to fructose-1-phosphate and fructose-1,6-bisphosphate
-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
A treatment can take as little as a few minutes to as long as an hour, depending on how many areas you're treating